Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis.

被引：0
|
作者：
Rumyantsev, Alexey
Tyulyandina, Alexandra
Fedyanin, Mikhail
Pokataev, Ilya
Glazkova, Elena
Israelyan, Edgar
Tjulandin, Sergei
机构：
[1] Minist Hlth Russian Federat NN Blokhin NMRCO, NN Blokhin Natl Med Res Ctr Oncol, Fed State Budgetary Inst, Moscow, Russia
[2] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
[3] NN Blokhin Natl Med Res Ctr Oncol, St Petersburg, Russia
[4] NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17551
引用
收藏
页码：E17551 / E17551
页数：1
相关论文
共 50 条
  • [1] OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer
    Park, Junsik
    Cho, Hyun Woong
    Lim, Myong Cheol
    Choi, Chel Hun
    Lee, Jung-Yun
    [J]. FUTURE ONCOLOGY, 2024,
  • [2] Treosulfan in platinum-resistant ovarian cancer
    Olesen, Katrine Dam
    Larsen, Anja Tolstrup Raedkjaer
    Jensen, Lars Henrik
    Steffensen, Karina Dahl
    Sondergaard, Stine Rauff
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (07) : 1045 - 1051
  • [3] Immunotherapy for platinum-resistant ovarian cancer
    Bogani, Giorgio
    Lopez, Salvatore
    Mantiero, Mara
    Ducceschi, Monika
    Bosio, Sara
    Ruisi, Simona
    Sarpietro, Giuseppe
    Guerrisi, Rocco
    Brusadelli, Claudia
    Dell'Acqua, Andrea
    Di Donato, Violante
    Raspagliesi, Francesco
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 484 - 488
  • [4] PLATINUM FREE INTERVAL PREDICTS RESPONSE TO PLATINUM RECHALLENGE IN PLATINUM-RESISTANT OVARIAN CANCER
    da Costa, A.
    Amorim, C. V. V.
    Saito, A.
    Ribeiro, A. R. R.
    Tariki, M. I. W.
    Guimaraes, A. P. G.
    Sanches, S.
    Mello, C. L.
    Prestes, J. C.
    Achatz, M. I. W.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 419 - 419
  • [5] Efficacy of platinum-based chemotherapy in platinum-resistant ovarian cancer: A systematic review with pooled analysis of outcomes
    Rumyantsev, A.
    Tyulyandina, A.
    Fedyanin, M.
    Pokataev, I.
    Glazkova, E.
    Nikulin, V.
    Tjulandin, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S625 - S626
  • [6] Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy
    Leitao, MM
    Hummer, A
    Dizon, DS
    Aghajanian, C
    Hensley, M
    Sabbatini, P
    Venkatraman, E
    Spriggs, DR
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 91 (01) : 123 - 129
  • [7] IS THERE A PLACE FOR PLATINUM REINDUCTION IN BRCA POSITIVE PLATINUM-RESISTANT OVARIAN CANCER?
    Zikan, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 880 - 880
  • [8] IS THERE A PLACE FOR PLATINUM REINDUCTION IN BRCA POSITIVE PLATINUM-RESISTANT OVARIAN CANCER?
    Zikan, M.
    Dubova, O.
    Sehnal, B.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A551 - A552
  • [9] Gemcitabine and anthracyclines in platinum-resistant ovarian cancer
    Galligioni, E.
    Arcuri, C.
    Sorio, R.
    Griso, C.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V195 - V198
  • [10] ECONOMIC BURDEN IN PLATINUM-RESISTANT OVARIAN CANCER
    Indukuri, Nikhila
    Musat, Mihaela
    Chavez, Gordon
    Proescholdt, Christina
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A142 - A142
12345